Sponsored Link:

Page Analysis

Sponsored Link:

mammaprint.nl


http://www.mammaprint.nl/
745 ratings.1242 user reviews.

Web page information

  1. Keywords hit in search results
    about agendia analyseert analyzes answers assess assessment based bepaalt borstkanker borsttumor breast breastcancer brochures cancer clearance cleared coloprint coming commercial company coverage delivers description determinare determine developments develops diagnostic diagnostische donna donne early enable encyclopedia ernstig everything expresion expression figure first following genes genetics genomic getting helps individualized information insurance ivdmia kenmerken mammaprint mammaprint® measures medico metastasis metastasize microarray migliore molto nauwkeurig operation operazione other parts patient patients permettera personalize physician physicians profile profiling prognosis prognostic providers provides quale quantitative questions recent relapse reproducible result risultato sample simple stage sviluppato symphony targetprint terapia testing tissue together treatment tumor wikipedia would
  2. Search Engine Recommended Keywords
    Oncotype DX, Agendia Inc, Agendia BV, Agendia Diagnostics, MammaPrint vs Oncotype DX, MammaPrint Genes, MammaPrint Test, MammaPrint Cost,
Hoe ernstig is uw borstkanker? | MammaPrint® test bij borstkanker
MammaPrint® is een diagnostische test bij borstkanker, het analyseert nauwkeurig de kenmerken van uw borsttumor en bepaalt hoe ernstig deze is.
http://www.mammaprint.nl/
SYMPHONY | Personalize Your Breast Cancer Treatment | Agendia
Why MammaPrint. MammaPrint Patient Brochures; Questions & Answers; FDA Clearance; Getting Your Symphony Profile; Symphony Providers; Insurance Coverage. Questions & Answers
http://www.agendia.com/
MammaPrint - MammaPrint - everything you need to know about MammaPrint
The MammaPrint result will enable your physician to determine what would be the best kind of treatment for you following your operation. The result of a MammaPrint is ...
http://www.mammaprint.co.uk/index.html
MammaPrint - Wikipedia, the free encyclopedia
MammaPrint is a diagnostic test used by physicians to assess the risk that a breast tumor will metastasize to other parts of the body. This helps physicians determine ...
http://en.wikipedia.org/wiki/Agendia
MammaPrint | Genomic Testing for Breast Cancer Prognosis and ...
MammaPrint Provides Individualized Metastasis Risk Assessment for Your Breast Cancer Patients. MammaPrint is the first and only FDA-cleared IVDMIA breast cancer ...
http://www.agendia.com/pages/mammaprint/21.php
MammaPrint - Recent developments
Together with the MammaPrint test result, this information can be used to determine your treatment. TargetPrint delivers reproducible, quantitative gene expression ...
http://www.mammaprint.co.uk/recent.html
MammaPrint Test - BreastCancer.org - Breast Cancer Treatment ...
The MammaPrint test by Agendia analyzes 70 genes from an early-stage breast cancer tissue sample to figure out if the cancer has a low or high risk of coming back ...
http://www.breastcancer.org/symptoms/testing/types/mammaprint.jsp
MammaPrint - sviluppato da una donna per le donne
Il risultato MammaPrint permettera' al tuo medico di determinare quale sara' la migliore terapia per te, dopo l'operazione.. Il risultato di MammaPrint e' molto ...
http://www.mammaprint.it/
MammaPrint - Simple Genetics
Description MammaPrint is commercial microarray 1 based prognostic breast cancer gene-expresion 2 profiling test of 70 genes. The MammaPrint test measures the level ...
http://genetics.wikidot.com/mammaprint
Is FDA Approval of MammaPrint a Big Step in Breast Cancer ...
However, the MammaPrint test is not the first of its kind, nor is it impeccably better than its opponent. It is simply the first to be approved by the FDA.
http://voices.yahoo.com/is-fda-approval-mammaprint-big-step-breast-198663.html

News Results

Agendia BV - Medical Equipment - Deals and Alliances Profile - new company profile report
The company develops and manufactures in vitro diagnostics for cancer detection. Its products include CupPrint, TargetPrint, TheraPrint and MammaPrint. Agendia develops molecular diagnostic procedures based on DNA microarray technology. These tests provide ...
Transworld News
ColoPrint aids prediction of colorectal cancer relapse
Drawing on previous experience from the development of MammaPrint (Agendia NV), a similar 70-gene tool designed to help predict breast cancer relapse, the researchers developed ColoPrint to improve relapse risk stratification in stage II colon ...
News-Medical.Net
No Coupons found for this website.

500 characters left

Your Review: (5 out of 5)
refresh captcha


Server Information
IP Address: 181.224.135.103
Server:Apache
Site Disclaimer:

All trademarks are the property of their respective owners. The facts, figures, reviews, records, stats, and other data presented on this page is for suggestion and information purposes only. PageGlimpse.com is not responsible for any incorrect or incomplete information. PageGlimpse.com does not take responsibility for any user-reviews of websites inside its resource and reserves the right to keep or remove those. It is highly recommended that you review all the data for accuracy.